This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Astellas Pharma Gmbh. Active years: 2020-2024.
Company Filing History:
Years Active: 2020-2024
Title: Tomohiro Eguchi: Innovator in Pharmaceutical Research
Introduction
Tomohiro Eguchi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for cancer. With a total of 4 patents to his name, Eguchi's work is recognized for its potential impact on cancer therapies.
Latest Patents
Eguchi's latest patents include a pharmaceutical composition comprising diamino heterocyclic carboxamide compounds as active ingredients. This composition is designed to treat AXL-related cancers, which can exhibit high expression of AXL or acquire resistance to anticancer agents through AXL activation. The specific compounds developed by Eguchi demonstrate an AXL inhibitory action, offering therapeutic effects for patients suffering from these types of cancer.
Another notable patent is the anti-human CD73 antibody, which has been enhanced compared to prior art. This antibody is capable of recovering AMP-dependently suppressed T cell functions, providing a promising avenue for improving immune responses in cancer treatment. The detailed structure of the antibody includes specific amino acid sequences that contribute to its enhanced functionality.
Career Highlights
Tomohiro Eguchi is currently associated with Astellas Pharma GmbH, where he continues to advance his research in pharmaceutical innovations. His work is characterized by a commitment to developing effective treatments that address critical health challenges.
Collaborations
Eguchi collaborates with esteemed colleagues, including Yoko Yamaki and Masamichi Mori, who contribute to the research and development efforts at Astellas Pharma GmbH. Their combined expertise fosters an environment of innovation and progress in the pharmaceutical field.
Conclusion
Tomohiro Eguchi's contributions to pharmaceutical research, particularly in cancer treatment, highlight his role as a leading inventor in the industry. His innovative patents and collaborative efforts continue to pave the way for advancements in medical science.